Search

Your search keyword '"Rodrigo-Troyano, A."' showing total 82 results

Search Constraints

Start Over You searched for: Author "Rodrigo-Troyano, A." Remove constraint Author: "Rodrigo-Troyano, A." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
82 results on '"Rodrigo-Troyano, A."'

Search Results

1. Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia

2. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions

3. Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity

7. Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study

8. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

9. Salivary immunity and lower respiratory tract infections in non-elite marathon runners.

10. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

14. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

15. Impact of Early Referral to Palliative Care in Patients with Interstitial Lung Disease

17. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

18. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

19. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

22. Antimicrobial peptides, disease severity and exacerbations in bronchiectasis

23. Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective (BMC Infectious Diseases, (2018), 18, 1, (677), 10.1186/s12879-018-3565-z)

24. EARLY HOSPITAL READMISSION INCREASES SHORT AND LONG - TERM MORTALITY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE

25. Drug related problems in clinical practice : a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions

26. Early hospital readmission increases short and long - term mortality in patients with interstitial lung disease

27. Drug related problems in clinical practice : a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions

29. Carga y factores de riesgo para la neumonía adquirida en la comunidad de Pseudomonas aeruginosa : un estudio multinacional de prevalencia puntual de pacientes hospitalizados

31. Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study

32. Patógenos atípicos en pacientes hospitalizados con neumonía adquirida en la comunidad: una perspectiva mundial

33. Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study

34. The respiratory threat posed by multidrug resistant Gram-negative bacteria

35. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study

36. Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?

37. Pseudomonas aeruginosaresistance patterns and clinical outcomes in hospitalized exacerbations of COPD

38. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

39. Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis

40. Airway FABP4 is decreased in COPD patients with airway bacterial infection

41. Pseudomonas aeruginosa en la enfermedad pulmonar obstructiva crónica; papel de los patrones de resistencia e impacto en las agudizaciones graves

42. Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity

43. Salivary immunity and lower respiratory tract infections in non-elite marathon runners

44. Salivary immunity and lower respiratory tract infections in non-elite marathon runners

45. The respiratory threat posed by multidrug resistant Gram-negative bacteria

46. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis

47. Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization

48. Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?

49. Multidrug-resistant pathogens in patients with pneumonia coming from the community

50. Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD

Catalog

Books, media, physical & digital resources